ArticleMolecular cancer therapeutics2021

Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma.

Yongmei Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.